Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia

Leuk Lymphoma. 2021 Sep;62(9):2295-2297. doi: 10.1080/10428194.2021.1901097. Epub 2021 Mar 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal
  • Arabinonucleosides
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Precursor Cells, T-Lymphoid*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Salvage Therapy

Substances

  • Antibodies, Monoclonal
  • Arabinonucleosides
  • daratumumab
  • nelarabine